MWNA
HGEN

Marshall Wace North America’s HUMANIGEN, INC. HGEN Stock Holding History

Marshall Wace North America’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-223,746
Closed -$3.89M – 1809
2021
Q2 		$3.89M Sell
223,746
-412,859
-65% -$7.53M 0.02% 626
2021
Q1 		$12.2M Buy
+636,605
New +$11.6M 0.05% 358

Other funds holding HGEN

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace North America's HGEN Position: Q3 2021 in Review

Marshall Wace North America sold out of HUMANIGEN, INC. (HGEN) in Q3 2021, closing a stake of 223,746 shares — an estimated $3.89M sold.

Marshall Wace North America first reported a position in HGEN in Q1 2021 and held it in 2 quarters. The position peaked at $12.2M in Q1 2021. 85 funds tracked by Wall St. Rank hold HGEN as of Q3 2021.

  • Marshall Wace North America reported no remaining HUMANIGEN, INC. position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 223,746 HUMANIGEN, INC. shares in Q3 2021, an estimated $3.89M.
  • Marshall Wace North America first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 2 quarters.
  • Marshall Wace North America's HUMANIGEN, INC. position peaked at $12.2M in Q1 2021.
  • 85 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.